Vithas: the second private hospital operator in Spain, with the vocation of being the first



On December 15, 2022, within the series “Breakfasts with health sector leaders“, organized by Roland Berger, a breakfast with Pedro Rico, General Director of Vithas, took place.

A summary of the breakfast content is as follows:

The origins

The Vithas group was officially presented on November 21, 2012, now celebrating the 10th anniversary of its origin. At that time, the group had 1,000 beds in 10 hospitals located in Madrid, Vigo, Alicante, Almería, Granada, Málaga, Lleida, Vigo, Vitoria, Las Palmas and Tenerife. Regarding its billing figures, the group reached 196 million euros.

At the beginning, the property was owned by the Goodgrower Group, linked to the Gallardo family, which held 80% of the shares and Criteria, with 20%. Subsequently, Goodgrower acquired the participation of Criteria, going on to hold 100% of the shares. From the beginning, the Presidency of Vithas has been in the hands of Jorge Gallardo Piqué.

A growth story

In 2014, Vithas incorporated the Xanit Internacional hospital (Benalmádena).

This same year, the Vithas Salud centers were created, designed as local specialty centers without hospitalization, and the Vithas Salud Fisium centers were incorporated in the province of Pontevedra.

In 2015 the group signed a strategic agreement with the Juaneda Assistance Network (Baleares). That year the new Vithas hospital was inaugurated in Granada and the five centers of the Rincón Clinics in the province of Malaga were acquired. The Lema and Bandín laboratories joined the Vithas group, renamed Vithas Lab.

In 2017 the expansion of the group gained new impetus with the acquisition of the 7 hospitals that made up the NISA group. This operation, together with the hospitals of Almería and Málaga and the shareholding agreement with the Juaneda Assistance Network, positioned Vithas as a leader in private healthcare throughout the Mediterranean arc

Growth continues in 2018 when the group takes another step towards the incorporation of highly specialized centers such as the Eurocanarias Ophthalmological Institute.

In January 2020, the group acquired the emblematic La Milagrosa hospital, located in the center of Madrid, consolidating the group’s presence in this city, where it already had two other hospitals, 1 specialty center and Vithas Internacional.

Vithas during the pandemic

During the pandemic, the group is 100% involved in patient care and actively collaborates with the authorities to deal with the health crisis, of course applying the corresponding internal protocols to ensure the safety of professionals.

It is worth highlighting two relevant initiatives in this field: the so-called Aerobox, a portable device for individual isolation of patients that prevents the transmission of the virus; and the solidarity project with other companies and institutions to develop OxyVita, an efficient and low-cost emergency ICU ventilator, which has been made available to all hospitals and health systems in the world in open source and free of rights.

Digital transformation as an integration tool

Since January 2020, the group has been promoting its digital transformation through the implementation of a new IT tool.

The idea is to overcome the old pre-existing hospital culture and move towards what is called Vithas one, in such a way that it has:

  • unique data
  • Single electronic medical record
  • single database
  • A centralized contact center

The will to create a centralized access for patients, gave rise to the launch in 2020 of a centralized contact center, as a high-performance center, where more than 120 operators work, understood as a strategic pillar of quality improvement. , recruitment, loyalty and customer satisfaction.

Impulse to Vithas diagnosis

In 2020, Vithas Diagnosis was launched, with an offer in clinical laboratory, imaging and pathological anatomy, with the idea of centralizing all of the company’s diagnostic activity and, at the same time, providing services to third parties.

My Vithas

This project tries to build the foundations of the digital experience for Vithas patients, incorporating the web and an app.

The result by 2022 is that there are already 669,034 digital users and 631,749 online appointments have been managed. At this moment, 14.6% of the group’s transactions are online.

New projects

Vithas’ desire for growth continues in 2022 with the construction of a new hospital in the province of Barcelona (where until now it had no presence), and another hospital in the south of Valencia, the third in this city. Both will mean a joint investment of more than 90 million euros.

During 2022, the Vithas Salud Gibraltar and Vithas Salud Alzira centers were inaugurated, as well as the expansion of the Vithas Madrid Arturo Soria surgical unit and the completion of the expansion of Vithas Xanit Internacional, which doubles its care capacity on the Costa del Sol.

Mainstreaming of specialties

This work was preceded by a definition of the Clinical Care and Governance Model of the strategic specialties.

After the launch of the Vithas Cardiovascular Institute, the Vithas Neurosurgery Unit and the Vithas Oncology Institute were created, adding to all the existing benefits a transversal and comprehensive assistance service specialized in each of these three major therapeutic areas.

The idea for the future is to boost the growth and activity of the institutes in operation and to promote research, as well as to continue with the territorial expansion of the Institutes model.

A great concern for quality

Quality is the central axis of the entire Vithas strategy. Apart from accreditation by the Joint Commission International, the patient experience is a core element of the “Vithas culture“. There is a Director of Patient Experience.

Vithas people

Based on the confirmation that professionals are the most important asset of Vithas, the aim is to promote a patient-focused organization that cares for its professionals.

For this, the approach is to offer future projects, internal promotion, training and recognition policies, with specific training plans (eg, IESE executive leadership, Master of Nursing).

Vithas’ university vocation

As a sign of its commitment to the training and development of healthcare talent, in November 2022, the three centers in Madrid (Vithas Madrid Arturo Soria, Vithas Madrid Aravaca and Vithas Madrid La Milagrosa) are accredited as university hospitals.

Vithas and research

As a sign of concern for research, the Vithas Foundation is promoting scientific publications, with an impact factor that grows every year, as well as conducting commercial clinical trials, the number of which also increases every year.

The “new” Vithas

During this time the appearance of Vithas has completely changed, the number of beds, ICU positions, internal consultations and surgical interventions have doubled; the volume of business, professionals and operating rooms has tripled; and the number of centers and patients attended has quadrupled.

But, apart from these quantitative data, there are other qualitative ones, no less important:

  • Concern for quality and patient experience
  • The promotion of the university character and teaching and research
  • digital transformation
  • The integration process of differentiated cultures
  • The “mainstreaming” of specialties, through the Institutes
  • The offer of a growth project to its professionals

That is why it is not hyperbole to speak of a new Vithas.

7 days in healthcare (September 26th-October 2nd, 2022)


From the point of view of Biomedicine, to review the advances, still to be confirmed, in the treatment of two terrible diseases: ALS and Alzheimer’s.

Regarding Global Health, concerns continue about the evolution of polio, whose eradication was announced in 2019, but which is reappearing in several countries.

Regarding International health policy, it is worth noting the similarities between the covid-zero policy in China and the era of prohibition in the United States, something pointed out by The Economist. Very worrying is the “burnout” of doctors, a phenomenon highlighted by the New York Times in the United States, but which seems to be universal.

If we talk about National health policy (Spain), the debates on the Equity Law continue. The update of the RD on the minimum data set of the SNS leaves out the private sector, despite the opposition of the POP, IMAS Foundation, IDIS Foundation and ASPE. It is a modification of a 2010 RD, but in twelve years the private sector has developed a lot and it is no longer so easy to leave it out in certain decisions. The Senate rejects the PP’s motion to facilitate access to medicines and reduce the time it takes to join the SNS. Surely the motion of the PP was too vague and, at this point, it is necessary to explain very well the “what” and the “how” of any proposal.

At the corporate level, at the international level, big rise in Biogen shares, spurred by what appear to be hopeful results from its Alzheimer’s drug. At the national level, there are rumors that KKR and CVC could be trying to buy Quirónsalud, currently in the hands of the German group Fresenius, which has recently changed its CEO. The Murcian company Vócali develops the Inbox Medical software for transcription of medical reports.


Global Health

International health policy

National health policy



7 days in healthcare (June 13th-20th, 2022)



From the point of view of biomedicine, to highlight the new therapy against a disease as terrible as ALS tested in Canada. Unfortunately there are doubts as to its effectiveness.

As far as Global Health is concerned, it is verified that it is the vaccine nationalism of the States that has led to the failure of COVAX, which failed to extend covid vaccination to poor countries in significant percentages.

Regarding international health policy, the approval in the United States of the covid vaccination for children under five years of age should be highlighted. Also the agreement of the World Trade Organization regarding the temporary suspension of patents on covid vaccines, something he was discussing for two years. We will see if this agreement translates into relevant measures. For now, the IFPMA (World Association of Pharmaceutical Manufacturers) has already spoken out against it. Hospitalizations for covid increase in Europe, specifically in France, Germany and the United Kingdom.

If we talk about national health policy (Spain), we must mention the controversial announcement by the Minister of Health of the fourth dose of covid for the entire population, something partially rectified by the Ministry itself and which has been rejected by many experts. Also the approval by the Government of the preliminary draft of the Equity Law. Great controversy with the private sector, since it tries to minimize and declare exceptional the collaboration of the private sector in the public service of the National Health System. But by declaring “direct management” as preferable in the SNS, it also positions itself against the more entrepreneurial development of public management, despite the fact that the benefits of legal personality and the labor regime are known in terms of greater efficiency than direct management. On the other hand, the draft may undermine the powers of the autonomous communities, since health management (and therefore the way of carrying it out) is a transferred matter. It is not surprising that very important Catalan institutions (such as UCH, CSC, ACES and Círculo de Sanidad) have taken a position against it. Important demonstration by nurses in the center of Madrid, highlighting the importance of the abandoned professional policy in the National System of Health.

In the field of companies, it is worth noting the birth of the largest pediatric oncology center in Spain and one of the largest in Europe: the one located in the Sant Joan de Deu Hospital in Barcelona. Expansión highlights that the remarkable growth of health insurance is compatible with a loss of its operating profitability.


Global health

International health policy

National health policy



Regulatory announcements

Other themes


7 days in healthcare (30th May-5th June, 2022)



From the point of view of biomedicine, to highlight the Science article, showing that the brain and the immune system are interconnected. Monkeypox is transmitted by direct contact, therefore “ring vaccination” is indicated, only to contacts of an infected person.

As far as Global Health is concerned, the universal coverage approach in Nigeria, the most populous country in Africa, should be highlighted. It is seen that universal coverage is no longer just something of Europe or the industrialized countries.

As for international health policy, the frequent shootings in American schools are covered by medical journals (The Lancet, British Medical Journal), as it is also a health problem. Something perfectly avoidable.

If we talk about national health policy (Spain), it should be mentioned that private health offers to collaborate with public health in addressing the problem of waiting lists.

In the field of companies, Takeda’s statements are surprising, saying that pharmaceutical companies will be able to lower prices in the face of a global crisis. The acquisition of the HIPRA vaccine by Brussels is advancing.


Global health

International health policy

  • Monkeypox

o 21 Americans affected by monkeypox, according to the CDC (

o New York Times editorial: To fight monkeypox we have to learn the lessons of covid and HIV ( hiv.html)

o Concern in Europe that massive summer parties spread monkeypox (

  • COVID-19

o Covid cases on the rise in the Americas: North and Central America) (

o Does the world need new covid vaccines? (

o Doubts about whether the arrival BA.4 and BA.5 of the omicron will mean a new wave of covid in France ( -l-arrivee-de-ba-4-et-ba-5-en-france-va-t-elle-entrainer-une-nouvelle-vague-de-contaminations_6128892_3244.html)

o The subvariant of the BA.5 omicron is a cause of concern in Portugal ( -restless_6128944_3244.html)

o The zero-covid policy in China is unfeasible in the long run, the only question is when it will abandon it to “live with covid”. Article in Science magazine (

  • Other themes

o The frequent shootings in American schools, also as a health problem, treated in medical journals. The Lancet:; British Medical Journal:

o The black market of antivirals for covid (

o Shortage of doctors in Italy (

o Medical abortion and telemedicine in a post-Roe v Wade phase (

o The Center for Medicare and Medicaid (CMS) in the USA plans to advance Value Based Healthcare (

National health policy

  • Monkeypox

o Spain reaches 132 positives for monkeypox (


o The incidence of covid in people over 60 years of age falls 45 points again ( .html)

  • Regulatory announcements

o The Order to allocate 217 places to non-EU citizens was published in the Official Bulletin (BOE) (

  • Other themes

o Private healthcare offers to reduce surgical waiting lists by 30%, according to ASPE ( offered-to-reduce-the-surgical-waiting-list-by-30.html)

o Aragon extends dental care up to 14 years of age (


  • International News

o GSK is going to buy the Affinivax biotech group for 3.0 billion dollars (

o BMS about to acquire drugmaker Turning Point for $4.1 billion (

o Takeda says that pharmaceutical companies could lower prices in the face of a global crisis (

o The company that manufactures the monkeypox vaccine has the capacity to produce 30 million doses ( -millions/676432695_0.html)

  • National News

o Brussels finalizes the acquisition of the HIPRA vaccine for covid ( -Hipra-for-the-Covid.html)

o HM acquires the Los Nogales Pontones center to build a new hospital ( hospital.html)

o Vithas recovers from the covid downturn and grows 19% in 2021 ( -Jan-19-2021.html)

o Grupo HLA targets 500 million revenues in 2022 (

o The contracting of medical insurance skyrockets in Cantabria and Catalonia in 2021. At the national level, 24% of the population has private medical insurance, although low cost ones are included (only consultations and tests) (https://www.

o The laboratories devastate the funds in their bid for Lacer (

o Vithas has an agenda to achieve the 2030 goals ( -phonebook-2030-9828)

o DKV presents the 2021 corporate report and the Imagina 2025 Strategic Plan (

7 days in healthcare (May 9th-15th, 2022)



From the point of view of biomedicine, the important study published by the journal Science should be highlighted, outlining the most detailed atlas of human cells to date. The discussion about the origin of acute childhood hepatitis continues.

As far as Global Health is concerned, it is found that the United States has reached one million deaths from COVID and Europe two million. A sad milestone.

Regarding international health policy, in relation to COVID, the debate continues on the sustainability of the zero-COVID policy in China. Lockdowns in North Korea, possibly the most opaque country in the world. The debate continues in the United States on the modification of the Roe v Wade sentence. Pronouncements from scientific journals (Nature, The Lancet), as well as from the President of the American Medical Association. The ECDC (European Center for Disease Prevention and Control) stops recommending the use of masks on public transport in Europe.

If we talk about national health policy (Spain), the accumulated incidence of COVID continues to grow. Great debate regarding the announced new Abortion Law. It is more than doubtful that the Law will be approved and, if it is, that it will be complied with, given the large number of controversial elements (registration of conscientious objectors, the obligation that these interventions be carried out in public hospitals, the use of terminology of obstetric violence, etc.). The Ministry of Industry takes out the first tender of the cutting-edge health PERTE. Important editorial in El País on waiting lists, which it presents as a scourge of the SNS.

In the field of companies, the WHO denounces attempts to whiten tobacco companies, by way of presenting themselves as green companies.


Global Health

International health policy

  • COVID-19

o The Director of the WHO affirms that the zero-covid policy in China is not sustainable (

o A study says that lifting the “zero COVID” policy in China could mean 1.5 million deaths ( -china-could-risk-16m-deaths-says-study)

o China considers the WHO statement on its zero COVID policy “irresponsible” (

o China renounces organizing the 2023 Asian Soccer Cup, due to the pandemic ( coupe-d-asie-2023-de-football-in-raison-de-la-pandemie-de-covid-19_6126096_3210.html)

o Confinement in North Korea, as the first cases of COVID are confirmed (

o Alert in the state of New York, due to the increase in cases (

  • The debate on abortion continues in the United States

o The pronouncement of medical and scientific journals continues against the annulment of the Roe v Wade ruling in the United States, for reasons of public health and worsening of the health of women and children, particularly those with fewer resources. Editorials in Nature ( and The Lancet ( 00870-4/fulltext), among others.

o Gerald E. Harmon, President of the AMA, the representation of American doctors, was “deeply concerned” about the impact on reproductive health in the United States of this possible modification ( delivering-care/population-care/why-leaked-abortion-opinion-antithetical-public-health)

o The New York Times assures that the annulment of same-sex marriage could be the next step ( abortion.html)

o Certain groups try to ban telemedicine prescription of pills that interrupt pregnancy (

  • Other themes

o The United States, willing to share vaccine technology with poor countries, says Biden (

o The European Union Aviation Safety Agency and the European Center for Disease Prevention and Control (ECDC), eliminate the recommendation to use masks in airports and during flights ( society/20220511/2dur4ogv7zemfkl5bbwmsitpme.html)

o Disposable electronic cigarettes are imposed among adolescents in France ( .html)

o France will stop requiring a mask on public transport starting next Monday, May 16 (

National health policy


o The accumulated incidence continues to rise, growing 13 points since the last measurement and standing at 856.65 cases in the last 14 days per 100,000 inhabitants. The ward occupancy rate is 5.80% and the ICU occupancy rate is 4.07% ( 321-deceased-ia-uploads-856-points_114645_102.html)

  • Regulatory announcements

o The Government willing to approve next Tuesday, May 17, a new abortion law at the initiative of the Ministry of Equality. The 14-week period for abortion to be considered legal is not modified. Most controversial points: 1. Without permission or information to parents from the age of 16; 2. No to surrogacy; 3. Registration of conscientious objectors; 4. Abortion in public hospitals; 5. Leave due to painful menstruation, outside the regulations of the common disease; 6. The terminology of obstetric violence is maintained (

o The need to strengthen public healthcare so that it can address the 74,000 abortions that are performed in the private sector ( -the-74000-abortions-that-now-derives-to-the-private.html)

o The Constitutional Court is preparing a ruling in favor of the 2010 Abortion Law for June, after an appeal by the PP, parked for 12 years ( -judgment-favorable-law-abortion_3423623/)

  • Other themes

o The Ministry of Industry is putting out to tender the Vanguard Health PERTE for the pharmaceutical and health products sector ( .pdf)

o Important editorial in El País on waiting lists, which it presents as a major problem for the SNS (

o War of figures in the strike of medical specialists in Madrid ( -already-of-temporary.html)

o Castilla y León intends to lower the surgical delay in six months by 21 days ( -surgical-in-6-months)

o The national 024 telephone line for suicide prevention is launched (

o The SNS Interterritorial Council gives the green light to the Mental Health Plan ( -con-practica-unanimidad), which is criticized by the President of the Spanish Society of Psychiatry, saying that “Mental Health needs professionals and intermediate centers, not apps” ( /-mental-health-needs-professionals-and-intermediate-centers-no-apps–8807)

o The Ministry publishes the list of 462 strategic medicines, which includes 249 active ingredients ( html)

o Private doctors ask insurers to raise their fees, which according to them have been frozen for 32 years (

o Andalusia can have up to 8 Faculties of Medicine, after the steps in Jaén and Almería only Huelva remains ( –3332), something (the proliferation of Medical Faculties) totally against the approaches of the CEEM (State Confederation of Medical Students) and the Conference of Deans

Companies, employers and other agents of the sector

  • International News

o The WHO asks countries to stop the tobacco companies that try to whitewash their image as a green industry ( to-the-countries-that-stop-the-tobacco- companies-that-try-to-clean-up-their-image-as-a-green-industry.html)

o Pfizer will buy the biotech company Biohaven for 11.6 billion dollars (

  • National News

o Vithas invests 3 million euros in the renovation of emergencies ( of-your-emergencies.html)

o Vitaldent is committed to dental aesthetics by incorporating 73 Smysecret spaces into its clinics ( -your-clinics.html)

o Asisa buys a 600m2 center in Zaragoza (

o Hospitales Parque grows in Talavera with a new building for outpatient consultations ( for-external-queries.html)

o Sanitas, SegurCaixa Adeslas and Línea Directa, the most profitable insurers (

o Novartis will manufacture an oncology drug for the whole world in Barcelona ( -world-.html)

7 days in healthcare (November 29-December 5, 2021)



From the international point of view, it is worth highlighting the beginning of the work of the WHO for the approval of a Treaty on pandemics. It seems that the alarm about the new “‘ ómicron “variant is lowered, after the WHO announcement that there had been no case of death. We must be attentive to the program of the new German coalition government, and its impact on the health system. It seems that its actions are concentrated in the pharmaceutical sector. The failure, for various reasons, of the COVAX platform for immunization of low- and middle-income countries is confirmed.

At the national level, the growth of COVID continues to figures that are already beginning to be worrying, despite the advantage over other European countries. The council of ministers approves the Mental Health Strategy, a plan that, unlike the one approved a few years ago on Primary Care, does have funding, despite having aroused reservations among experts. The council of ministers also approves the PERTE for health. As of December 13, the vaccines for children will be available.

Regarding companies, it should be noted that both Pfizer and Moderna are preparing to adapt their vaccines to the new COVID variant.




  • The WHO agrees on December 1, 2021 to begin negotiating an international agreement on how countries should prevent, prepare for and react to pandemics. The agreement is to hold a meeting before March 1, 2022 and discuss a draft before August 1, 2022 (British Medical Journal, Dec 2, 21)
  • A law to introduce dental care in Medicare is discussed in the American Congress (NEJM, 2 Dec 21)
  • An article is published that compares the evolution and behavior in 24 months of a large number of people from the Veterans Administration vaccinated with Moderna and Pfizer-BioNTech (NEJM, Dec 1 21)
  • The need for the health sector to contribute to decarbonization continues to be present (NEJM, Dec 2 21)
  • The WHO warns of a high risk due to the new “omicron” variant (FT Nov 29, 21)
  • WHO says there have been no deaths from the new “omicron” variant, despite its expansion (The Guardian, 4 Dec 21)
  • The “ómicron” variant, with a wide worldwide diffusion: apart from its origin in South Africa, and the expansion to 11 European countries, also present in Canada, Brazil, Australia and Saudi Arabia, among others (CNN Español, Dec 1 21)
  • Van der Leyden calls to discuss the mandatory nature of the vaccine (FT, Dec 1 21)
  • Analysts say that the economic impact of the “omicron” variant will not be important (FT, Nov 29, 21)
  • The program of the new German coalition government has an impact on the healthcare and pharmaceutical sector. Most important measures: price containment in medicines, push for healthcare digitization and use of medical data for research (Covington, Nov 29 21)
  • Biden rules out a new lockdown to tackle the new “omicron” variant (FT, Nov 29, 21)
  • The United Kingdom urgently calls a meeting of the G7 to discuss the problem of the new variant (La Razón, 28 Nov 21)
  • The new variant presents more than 50 mutations over the original from Wuhan (La Razón, Nov 29, 21)
  • COVAX has only distributed 26% of the promised covid vaccines for 2021. The most unanimous explanation is that rich countries have monopolized the market (El Español, Dec 4, 21)
  • The EMA would need three to four months to approve vaccines if they have to be modified by “omicron” (El Confidencial, Nov 30, 21)
  • Europe steps on the accelerator with the third doses in full uncertainty for the new variant (, Nov 29, 21)
  • The lack of vaccines, logistical limitations and the rejection of part of the population hinder immunization in Africa (El País, 28 Nov 21)
  • Germany imposes a de facto confinement to the unvaccinated: leisure and commerce will be banned (El País, 2 Dec 21)
  • Agreement between the Council and the European Parliament to strengthen the role of the ECDC (El Global, 30 Nov 21)



  • COVID cases continue to rise, reaching an AI (cases per 100,000 in the last 14 days) of almost 250 (El Confidencial, Dec 3, 21)
  • Health advises limiting participants in social events during Christmas after the advance of COVID (La Razón 1 Dec 21)
  • The government does not have a “legal plan B” before the “omicron”, it trusts everything to vaccination and rejects restrictions that could affect the economy (La Razón, Dec 1 21)
  • The Government defends the need for an International Treaty on Pandemics, as stated by Minister Darias during the Extraordinary Assembly of the WHO in Geneva (ConSalud, 29 Nov 21)
  • The Council of Ministers approves the Mental Health Strategy 2022-2026, the last was of 2009. It is criticized by experts (Spanish Society of Psychiatry, Spanish Society of Dual Pathology) for its lack of ambition, although the effort of consensus. Among the criticisms is the lack of standards such as professional ratios, number of beds in children’s and adolescent hospitals, waiting lists, etc. It has financing of 100 million euros for the next three years, 30 million for 2022. Intervention in the workplace, the approach to suicide and the gender perspective, among the novelties of this Strategy (El Mundo, Dec 4, 21)
  • The council of ministers officially approves the PERTE for health. Investment of more than 1,400 million euros, between 2021 and 2023. These investment agendas are articulated through tenders, the creation of an investment, development and innovation (R + D + i) structure for advanced online therapies, launch of a public-private investment vehicle in advanced therapies (public-private commercial company) with the participation of companies with production capacity in Spain, elements of early coordination and identification of capacities and needs of the National Health System, public procurement innovative and pre-commercial, agreements with communities, private initiatives and co-programmed projects and public tenders (PlantaDoce, Nov 30 21)
  • The Interterritorial Council of December 2 addresses the Royal Decree of Specialties, so that it is approved before the end of 2021. It contemplates approving new specialties and reviewing access to specific training areas (ConSalud, Nov 30, 21)
  • Pfizer vaccines for children, available from December 13 (ConSalud, Dec 1 21)
  • AESEG presents a report “The sector of generic drugs in the economic and social reconstruction of Spain”, in which it advocates a differential price of generics in relation to brands (AESEG, Dec 1 21)



  • Continuity of care, interoperability, innovation and the promotion of the SDGs (Sustainable Development Goals), among the objectives of the IDIS Foundation for 2022 (ConSalud, 2 Dec 21)
  • Teladoc Health grows 81% in the third quarter (PlantaDoce, Dec 1 21)
  • Pfizer and Moderna are preparing to adapt their vaccines to the new “omicron” variant (El Global, Nov 29, 29)
  • Merck’s COVID Treatment (Molnupiravir), Endorsed by FDA (NYT, Nov 30 21)
  • HM Hospitales will have a new space of 1,000 square meters in Valdedebas (PlantaDoce, Nov 30, 21)
  • HIPRA relies on its covid vaccine to grow 13% in 2021 (PlantaDoce, Dec 1 21)
  • The major private equity companies (CVC, Advent, Cinven, PAI, KKR,…) prepare offers for around 1,500 million for IVI (CincoDías, Nov 30, 21)